Catalyst Pharmaceuticals Inc (CPRX)
21.12
-0.03
(-0.14%)
USD |
NASDAQ |
Nov 21, 16:00
21.25
+0.13
(+0.62%)
Pre-Market: 08:51
Catalyst Pharmaceuticals Total Assets (Quarterly): 772.01M for Sept. 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 772.01M |
| June 30, 2024 | 706.36M |
| March 31, 2024 | 646.68M |
| December 31, 2023 | 470.11M |
| September 30, 2023 | 413.21M |
| June 30, 2023 | 443.90M |
| March 31, 2023 | 407.23M |
| December 31, 2022 | 375.63M |
| September 30, 2022 | 333.11M |
| June 30, 2022 | 267.31M |
| March 31, 2022 | 246.97M |
| December 31, 2021 | 237.79M |
| September 30, 2021 | 223.25M |
| June 30, 2021 | 209.13M |
| March 31, 2021 | 197.22M |
| December 31, 2020 | 192.35M |
| September 30, 2020 | 174.86M |
| June 30, 2020 | 131.41M |
| March 31, 2020 | 117.88M |
| December 31, 2019 | 112.38M |
| September 30, 2019 | 96.69M |
| June 30, 2019 | 78.23M |
| March 31, 2019 | 61.08M |
| December 31, 2018 | 60.45M |
| September 30, 2018 | 67.71M |
| Date | Value |
|---|---|
| June 30, 2018 | 74.29M |
| March 31, 2018 | 79.13M |
| December 31, 2017 | 85.39M |
| September 30, 2017 | 34.63M |
| June 30, 2017 | 35.98M |
| March 31, 2017 | 37.70M |
| December 31, 2016 | 41.71M |
| September 30, 2016 | 45.31M |
| June 30, 2016 | 48.94M |
| March 31, 2016 | 53.67M |
| December 31, 2015 | 60.10M |
| September 30, 2015 | 64.56M |
| June 30, 2015 | 68.34M |
| March 31, 2015 | 76.05M |
| December 31, 2014 | 43.91M |
| September 30, 2014 | 45.84M |
| June 30, 2014 | 45.93M |
| March 31, 2014 | 22.23M |
| December 31, 2013 | 25.37M |
| September 30, 2013 | 28.70M |
| June 30, 2013 | 12.55M |
| March 31, 2013 | 14.47M |
| December 31, 2012 | 16.79M |
| September 30, 2012 | 12.11M |
| June 30, 2012 | 7.704M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
112.38M
Minimum
Dec 2019
772.01M
Maximum
Sep 2024
333.94M
Average
257.14M
Median
Total Assets (Quarterly) Benchmarks
| Corcept Therapeutics Inc | 784.26M |
| Vertex Pharmaceuticals Inc | 22.24B |
| Sarepta Therapeutics Inc | 3.600B |
| ADMA Biologics Inc | 390.62M |
| BioVie Inc | 21.24M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 111.07M |
| Shareholders Equity (Quarterly) | 660.94M |
| Current Ratio | 5.114 |